Global X S&P Biotech ETF (ASX:CURE)
ETF Securities (ASX:CURE) ETF. The ETFS CURE ETF provides investors with exposure to the US biotechnology sub-industry within the health care sector. CURE adopts an equally weighted strategy, which allocates greater exposure to small and mid-cap shares compared to a market capitalisation weighted approach.View our FULL REPORT on ETF Securities CURE ETF (ASX:CURE).
Global X S&P Biotech ETF (ASX:CURE) share price
Global X S&P Biotech ETF (ASX:CURE) passive income
Global X S&P Biotech ETF (ASX:CURE) share price news
ASX Growth Shares
Investing in Artificial Intelligence: investing in ETFs or stocks for AI
On The Australian Investors Podcast today, Owen Rask is joined by Blair Hannon of Global X ETFs to talk about the ways to play investing in Artificial Intelligence (AI). The duo talk about ETFs, stocks like NVIDIA, TECH, FANG and more.
June 28, 2023
Editor's picks
The vaccines of tomorrow: how to invest in biotechnology
Biotechnology has experienced extraordinary growth in recent times and came to popular attention as companies raced to find vaccines and cures for COVID-19.
December 2, 2020
Australian Finance Podcast
How To Build An ETF Portfolio, With Kris Walesby Of ETF Securities
In this episode of The Australian Finance Podcast, Owen talks with ETF Securities CEO, Kris Walesby, about his journey, where
July 13, 2020
ASX Share Ideas
Is This The ASX’s Healthiest ETF?
One ASX ETF that could boost the returns of your portfolio is the ETFS S&P Biotech ETF (ASX: CURE). Here are some of the opportunities and risks.
July 16, 2019